#Metaregression
Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer’s disease: a cumulative meta-analysis and trial sequential analysis
Blanco-Silvente L, Castells X, Garre-Olmo J, Vilalta-Franch J, Saez M, Barceló MA, Capellá D. European Journal of Clinical Pharmacology 2019; 75(12):1659-1667. doi: 10.1007/s00228-019-02742-w (Impact Factor: 2.953, PHARMACOLOGY & PHARMACY 144/271 Q3)
Discontinuation, efficacy and safety of cholinesterase inhibitors for Alzheimer’s disease: a meta-analysis and meta-regression of 44 randomized clinical trials enrolling 16.245 patients
Blanco L, Castells X, Saez M, Barceló MA, Garre J, Vilalta J, Capellà D. International Journal of Neuropsychopharmacology 2017; 20(7):519-528. doi: 10.1093/ijnp/pyx012 (Impact Factor: 4.207, CLINICAL NEUROLOGY, 40/199 Q1)